Skip to content

Comparison of Analgesic Requirements in Patients Receiving Nuss Operation Using 2 Different Anesthetic Adjuvants

Comparing Analgesic Requirements in Patients Receiving Nuss Operation Using Remifentanil or Dexmedetomidine as Anesthetic Adjuvants

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04073758
Acronym
ARNRD
Enrollment
62
Registered
2019-08-29
Start date
2019-09-02
Completion date
2021-02-28
Last updated
2020-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chest Wall Disorder

Keywords

Pectus Excavatum

Brief summary

Nowadays, general anaesthesia is carried under balanced anesthesia technique in which many anesthetic adjuvants are used simultaneously, including opioid analgesics in order to reduce the amount of inhalation agents. The most popular adjuvants used are remifentanil, which is an opioid analgesic, and dexmedetomidine. Both of these agents are short acting, can be infused with targeted concentrations, excreted shortly from the body with stable hemodynamics. Remifentanil, when infused for more than 2 hours, causes hyperalgesia to increase the amount of pain postoperatively as well as the amount of opioid analgesics. However, dexmedetomidine does not cause hyperalgesia and is known to have an opioid -sparing effect. In our center. In this study, we aim to compare the effects of remifentanil and dexmedetomidine on postoperative pain in patients undergoing Nuss procedure, which is a very painful operation on the chest wall.

Interventions

DRUGDexmedetomidine

Comparing effects of remifentanil versus dexmedetomidine

Sponsors

Jung Min Koo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

1. Adults aged \>20 2. Patients undergoing Nuss bar operation (pectus excavatum repair surgery) 3. American Society of Anesthesiologists classification I \ III

Exclusion criteria

1. Drug abuse history 2. Chronic pain in need of continuous opioid analgesics administration 3. History of psychiatric diseases 4. Preoperative bradycardia (heart rate \< 50/min) or arrythmia 5. Cardiac diseases other than diabetes or hypertension - coronary artery disease, ischemic heart disease 6. Moderate liver or kidney dysfunction 7. Pregnant or breast feeding women 8. Hypersensitivity to the study drugs 9. Patients who do not agree to participate

Design outcomes

Primary

MeasureTime frameDescription
Visual Analogue ScaleBetween 1~6 hours postoperatively.Pain scale ranges from 0 to 10. 0 means no pain at all, and 10 being the most severe pain anyone can imagine.

Secondary

MeasureTime frameDescription
Amount of fentanyl used postoperatively at the recovery unitAt 60 minutes after the end of surgeryAmount in micgrograms per wegith in kilograms (migrogram/kilogram)
Time needed for postoperative rescue opioid analgesicsAt 60 minutes after the end of surgery
Amount of remifentanil or dexmedetomidine used intraoperativelyImmediately at the end of the surgery
Intraoperative hemodynamic change: Systolic blood pressure1 minute after monitoring (of blood pressure, heart rate, pulse oxymeter and electrocardiogram) starts, when the patient arrives at the operating room
Amount of postoperative intravenous patient controlled analgesics (PCA) usedAt 60 minutes after the end of surgery
Intraoperative hemodynamic change: mean blood pressure1 minute after monitoring (of blood pressure, heart rate, pulse oxymeter and electrocardiogram) starts, when the patient arrives at the operating room
Intraoperative hemodynamic change: heart rate30 minutes after the induction of anesthesia
Rescue drugs (inotropics or vasopressors) used in order to correct hypotension or bradycardiaIntraoperatively
Postoperative complicationsBetween 1~6 hours postoperativelyNumber of events that happened to the patient: e.g. Yes or No, and how many times. Nausea/vomiting, hypotension, respiratory depression, urinary retension, dizziness, transient cease in use of intravenous patient controlled analgesics (PCA)
Intraoperative hemodynamic change: Diastolic blood pressure1 minute after monitoring (of blood pressure, heart rate, pulse oxymeter and electrocardiogram) starts, when the patient arrives at the operating room

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026